Invesco Biotechnology & Genome ETF (PBE)

PBE Holdings List

As of May 23, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	NBIX	Neurocrine Biosciences, Inc.	5.60%	101,907
2	NTRA	Natera, Inc.	5.30%	75,711
3	GILD	Gilead Sciences, Inc.	5.20%	105,904
4	BIIB	Biogen Inc.	4.73%	82,326
5	UTHR	United Therapeutics Corporation	4.65%	33,042
6	AMGN	Amgen Inc.	4.65%	37,418
7	ILMN	Illumina, Inc.	4.53%	123,347
8	REGN	Regeneron Pharmaceuticals, Inc.	4.39%	16,327
9	PTGX	Protagonist Therapeutics, Inc.	3.83%	183,594
10	BCRX	BioCryst Pharmaceuticals, Inc.	3.76%	777,314
11	TGTX	TG Therapeutics, Inc.	3.48%	220,557
12	CPRX	Catalyst Pharmaceuticals, Inc.	3.47%	309,732
13	ACAD	ACADIA Pharmaceuticals Inc.	3.40%	338,563
14	EXEL	Exelixis, Inc.	3.38%	174,345
15	EXAS	Exact Sciences Corporation	3.34%	128,258
16	BPMC	Blueprint Medicines Corporation	3.27%	70,600
17	QGEN	Qiagen N.V.	3.12%	162,132
18	COLL	Collegium Pharmaceutical, Inc.	2.95%	223,546
19	RPRX	Royalty Pharma plc	2.83%	191,051
20	HALO	Halozyme Therapeutics, Inc.	2.77%	111,094
21	PTCT	PTC Therapeutics, Inc.	2.69%	127,933
22	INCY	Incyte Corporation	2.54%	86,498
23	VCYT	Veracyte, Inc.	2.39%	192,363
24	CDNA	CareDx, Inc	2.39%	308,094
25	BMRN	BioMarin Pharmaceutical Inc.	2.38%	90,445
26	DVAX	Dynavax Technologies Corporation	2.15%	479,993
27	MNKD	MannKind Corporation	2.14%	1,139,148
28	TECH	Bio-Techne Corporation	2.14%	100,224
29	XNCR	Xencor, Inc.	1.54%	445,415
30	MYGN	Myriad Genetics, Inc.	0.98%	548,169
31	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	0.02%	46,776
32	n/a	Cash	0.00%	5,728
33	n/a	Securities Lending - Bnym	0.00%	1

As of May 23, 2025